64 |
ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings |
Department of Clinical Pathology |
2023 |
65 |
Prognostic value of echocardiographic indices in risk stratification of intermediate-risk pulmonary embolism |
Department of Chest Diseases |
2023 |
66 |
Derangement of Basic Amino Acids and Nitric Oxide Levels in Patients Undergoing Cardiothoracic Surgery |
Department of Biochemistry |
2023 |
67 |
Ameliorative effects of zinc oxide, in either conventional or nanoformulation, against bisphenol A toxicity on reproductive performance, oxidative status, gene expression |
Department of Anatomy |
2023 |
68 |
The prognostic value of post thyroidectomy Tc-99m pertechnetate thyroid scan in patients with differentiated thyroid cancer |
Department of Clinical Oncology and Nuclear Medicine |
2023 |
69 |
A meta analysis on the utility of Anakinra in severe COVID-19 disease |
Department of Chest Diseases |
2023 |
70 |
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase 1 Gene Polymorphisms and Thrombophilia Markers as Risk Factors for 2 Recurrent unexplained Miscarriage |
Department of Clinical Pathology |
2023 |
71 |
Quercetin Alleviated Inflammasome-Mediated Pyroptosis and Modulated the mTOR/P70S6/P6/eIF4E/4EBP1 Pathway in Ischemic Stroke |
Department of Pharmacology |
2023 |
72 |
Prognostic value of echocardiographic indices in risk stratification of intermediate‑risk pulmonary embolism |
Department of Chest Diseases |
2023 |